Dowling, J. E. in Encyclopedia of the Human Brain, Vol. 4 (ed. Ramachandran, V.) 217–235 (Academic Press, San Diego, 2002). Book Google Scholar Berson, D. M. in The Senses: A Comprehensive Reference, Vol. 1 (eds Basbaum, A. I. et al.) 491–519 (Elsevier, New York, 2008). Book Google Scholar Faden, A. I. & Salzman, S. Pharmacological strategies in CNS trauma. Trends Pharmacol. Sci. 13, 29–35 (1992). Article CAS PubMed Google Scholar Schwartz, M., Belkin, M., Yoles, E. & Solomon, A. Potential treatment modalities for glaucomatous neuropathy: neuroprotection and neuroregeneration. J. Glaucoma 5, 427–432 (1996). CAS PubMed Google Scholar Crowe, M. J., Bresnahan, J. C., Shuman, S. L., Masters, J. N. & Beattie, M. S. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 3, 73–76 (1997). Article CAS PubMed Google Scholar Levkovitch-Verbin, H. et al. Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 42, 975–982 (2001). CAS PubMed Google Scholar Levkovitch-Verbin, H. et al. A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection. Invest. Ophthalmol. Vis. Sci. 44, 3388–3393 (2003). Article PubMed Google Scholar Yoles, E. & Schwartz, M. Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies. Exp. Neurol. 153, 1–7 (1998). Article CAS PubMed Google Scholar Benowitz, L. & Yin, Y. Rewiring the injured CNS: lessons from the optic nerve. Exp. Neurol. 209, 389–398 (2008). Article CAS PubMed Google Scholar Vidal-Sanz, M., Bray, G. M., Villegas-Perez, M. P., Thanos, S. & Aguayo, A. J. Axonal regeneration and synapse formation in the superior colliculus by retinal ganglion cells in the adult rat. J. Neurosci. 7, 2894–2909 (1987). Article CAS PubMed PubMed Central Google Scholar Keirstead, S. A. et al. Electrophysiologic responses in hamster superior colliculus evoked by regenerating retinal axons. Science 246, 255–257 (1989). Article CAS PubMed Google Scholar Villegas-Perez, M. P., Vidal-Sanz, M., Bray, G. M. & Aguayo, A. J. Influences of peripheral nerve grafts on the survival and regrowth of axotomized retinal ganglion cells in adult rats. J. Neurosci. 8, 265–280 (1988). Article CAS PubMed PubMed Central Google Scholar Moalem, G. et al. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5, 49–55 (1999). Article CAS PubMed Google Scholar Kipnis, J. et al. T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc. Natl Acad. Sci. USA 97, 7446–7451 (2000). Article CAS PubMed PubMed Central Google Scholar Lingor, P. et al. Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo. J. Neurochem. 103, 181–189 (2007). CAS PubMed Google Scholar Schwab, M. E. Nogo and axon regeneration. Curr. Opin. Neurobiol. 14, 118–124 (2004). Article CAS PubMed Google Scholar Lehmann, M. et al. Inactivation of Rho signaling pathway promotes CNS axon regeneration. J. Neurosci. 19, 7537–7547 (1999). Article CAS PubMed PubMed Central Google Scholar Fischer, D., He, Z. & Benowitz, L. I. Counteracting the Nogo receptor enhances optic nerve regeneration if retinal ganglion cells are in an active growth state. J. Neurosci. 24, 1646–1651 (2004). Article CAS PubMed PubMed Central Google Scholar Silver, J. & Miller, J. H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5, 146–156 (2004). Article CAS PubMed Google Scholar Rolls, A. et al. Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation. PLoS Med. 5, e171 (2008). Article PubMed PubMed Central Google Scholar Filbin, M. T. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat. Rev. Neurosci. 4, 703–713 (2003). Article CAS PubMed Google Scholar David, S. & Aguayo, A. J. Axonal elongation into peripheral nervous system “bridges” after central nervous system injury in adult rats. Science 214, 931–933 (1981). Article CAS PubMed Google Scholar Streilein, J. W. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 3, 879–889 (2003). Article CAS PubMed Google Scholar Kaur, C., Foulds, W. S. & Ling, E. A. Blood–retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog. Retin. Eye Res. 27, 622–647 (2008). Article CAS PubMed Google Scholar Wilbanks, G. A. & Streilein, J. W. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-β. Eur. J. Immunol. 22, 1031–1036 (1992). Article CAS PubMed Google Scholar Taylor, A. W. & Streilein, J. W. Inhibition of antigen-stimulated effector T cells by human cerebrospinal fluid. Neuroimmunomodulation 3, 112–118 (1996). Article CAS PubMed Google Scholar Cheung, N. et al. Retinal microvascular abnormalities and subclinical magnetic resonance imaging brain infarct: a prospective study. Brain 133, 1987–1993 (2010). Article PubMed PubMed Central Google Scholar Wong, T. Y. et al. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet 358, 1134–1140 (2001). Article CAS PubMed Google Scholar Wong, T. Y. et al. Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv. Ophthalmol. 46, 59–80 (2001). Article CAS PubMed Google Scholar Wong, T. Y. et al. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 288, 67–74 (2002). Article PubMed Google Scholar Kalesnykas, G., Tuulos, T., Uusitalo, H. & Jolkkonen, J. Neurodegeneration and cellular stress in the retina and optic nerve in rat cerebral ischemia and hypoperfusion models. Neuroscience 155, 937–947 (2008). Article CAS PubMed Google Scholar Baker, M. L., Hand, P. J., Wang, J. J. & Wong, T. Y. Retinal signs and stroke: revisiting the link between the eye and brain. Stroke 39, 1371–1379 (2008). Article PubMed Google Scholar Patton, N. et al. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J. Anat. 206, 319–348 (2005). Article PubMed PubMed Central Google Scholar Wardlaw, J. M. et al. Lacunar stroke is associated with diffuse blood–brain barrier dysfunction. Ann. Neurol. 65, 194–202 (2009). Article PubMed Google Scholar Wardlaw, J. M., Sandercock, P. A., Dennis, M. S. & Starr, J. Is breakdown of the blood–brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 34, 806–812 (2003). Article CAS PubMed Google Scholar Leibowitz, U. & Alter, M. Optic nerve involvement and diplopia as initial manifestations of multiple sclerosis. Acta Neurol. Scand. 44, 70–80 (1968). Article CAS PubMed Google Scholar McDonald, W. I. & Barnes, D. The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system. J. Neurol. Neurosurg. Psychiatry 55, 747–752 (1992). Article CAS PubMed PubMed Central Google Scholar Sorensen, T. L., Frederiksen, J. L., Bronnum-Hansen, H. & Petersen, H. C. Optic neuritis as onset manifestation of multiple sclerosis: a nationwide, long-term survey. Neurology 53, 473–478 (1999). Article CAS PubMed Google Scholar Patel, S. J. & Lundy, D. C. Ocular manifestations of autoimmune disease. Am. Fam. Physician 66, 991–998 (2002). PubMed Google Scholar Soderstrom, M. Optic neuritis and multiple sclerosis. Acta Ophthalmol. Scand. 79, 223–227 (2001). Article CAS PubMed Google Scholar Ghezzi, A. et al. Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests. J. Neurol. 246, 770–775 (1999). Article CAS PubMed Google Scholar Firth, D. The case of Augustus d'Este (1794–1848): the first account of disseminated sclerosis: (Section of the History of Medicine). Proc. R. Soc. Med. 34, 381–384 (1941). CAS PubMed PubMed Central Google Scholar Fisher, J. B. et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 113, 324–332 (2006). Article PubMed Google Scholar Monteiro, M. L., Fernandes, D. B., Apostolos-Pereira, S. L. & Callegaro, D. Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using fourier-domain optical coherence tomography. Invest. Ophthalmol. Vis. Sci. 53, 3959–3966 (2012). Article PubMed Google Scholar Green, A. J., McQuaid, S., Hauser, S. L., Allen, I. V. & Lyness, R. Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 133, 1591–1601 (2010). Article PubMed PubMed Central Google Scholar Kerrison, J. B., Flynn, T. & Green, W. R. Retinal pathologic changes in multiple sclerosis. Retina 14, 445–451 (1994). Article CAS PubMed Google Scholar Gundogan, F. C., Tas, A., Erdem, U. & Sobaci, G. Retinal pathology in multiple sclerosis: insight into the mechanisms of neuronal pathology. Brain 134, e171; author reply e172 (2011). Article PubMed Google Scholar Masson, G., Mestre, D. & Blin, O. Dopaminergic modulation of visual sensitivity in man. Fundam. Clin. Pharmacol. 7, 449–463 (1993). Article CAS PubMed Google Scholar Santano, C., Pérez de Lara, M. & Pintor, J. in Studies on Experimental Models (eds Basu, S. & Wiklund, L.) 221–250 (Humana Press, New York, 2011). Book Google Scholar Archibald, N. K., Clarke, M. P., Mosimann, U. P. & Burn, D. J. The retina in Parkinson's disease. Brain 132, 1128–1145 (2009). Article PubMed Google Scholar Devos, D. et al. ERG and anatomical abnormalities suggesting retinopathy in dementia with Lewy bodies. Neurology 65, 1107–1110 (2005). Article CAS PubMed Google Scholar Moschos, M. M. et al. Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur. J. Ophthalmol. 21, 24–29 (2011). Article PubMed Google Scholar Inzelberg, R., Ramirez, J. A., Nisipeanu, P. & Ophir, A. Retinal nerve fiber layer thinning in Parkinson disease. Vision Res. 44, 2793–2797 (2004). Article PubMed Google Scholar Altintas, O., Iseri, P., Ozkan, B. & Caglar, Y. Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc. Ophthalmol. 116, 137–146 (2008). Article PubMed Google Scholar Hajee, M. E. et al. Inner retinal layer thinning in Parkinson disease. Arch. Ophthalmol. 127, 737–741 (2009). Article PubMed Google Scholar Onofrj, M., Ghilardi, M. F., Basciani, M. & Gambi, D. Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine function in humans. J. Neurol. Neurosurg. Psychiatry 49, 1150–1159 (1986). Article CAS PubMed PubMed Central Google Scholar Chiu, K. et al. Neurodegeneration of the retina in mouse models of Alzheimer's disease: what can we learn from the retina? Age (Dordr.) 34, 633–649 (2012). Article CAS Google Scholar Guo, L., Duggan, J. & Cordeiro, M. F. Alzheimer's disease and retinal neurodegeneration. Curr. Alzheimer Res. 7, 3–14 (2010). Article CAS PubMed Google Scholar Danesh-Meyer, H. V., Birch, H., Ku, J. Y., Carroll, S. & Gamble, G. Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging. Neurology 67, 1852–1854 (2006). Article CAS PubMed Google Scholar Hinton, D. R., Sadun, A. A., Blanks, J. C. & Miller, C. A. Optic-nerve degeneration in Alzheimer's disease. N. Engl. J. Med. 315, 485–487 (1986). Article CAS PubMed Google Scholar Blanks, J. C., Hinton, D. R., Sadun, A. A. & Miller, C. A. Retinal ganglion cell degeneration in Alzheimer's disease. Brain Res. 501, 364–372 (1989). Article CAS PubMed Google Scholar Blanks, J. C., Torigoe, Y., Hinton, D. R. & Blanks, R. H. Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol. Aging 17, 377–384 (1996). Article CAS PubMed Google Scholar Blanks, J. C. et al. Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL. Neurobiol. Aging 17, 385–395 (1996). Article CAS PubMed Google Scholar Parisi, V. et al. Morphological and functional retinal impairment in Alzheimer's disease patients. Clin. Neurophysiol. 112, 1860–1867 (2001). Article CAS PubMed Google Scholar Berisha, F., Feke, G. T., Trempe, C. L., McMeel, J. W. & Schepens, C. L. Retinal abnormalities in early Alzheimer's disease. Invest. Ophthalmol. Vis. Sci. 48, 2285–2289 (2007). Article PubMed Google Scholar Iseri, P. K., Altinas, O., Tokay, T. & Yuksel, N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J. Neuroophthalmol. 26, 18–24 (2006). Article PubMed Google Scholar Sadun, A. A. & Bassi, C. J. Optic nerve damage in Alzheimer's disease. Ophthalmology 97, 9–17 (1990). Article CAS PubMed Google Scholar Goldstein, L. E. et al. Cytosolic β-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease. Lancet 361, 1258–1265 (2003). Article CAS PubMed Google Scholar Ning, A., Cui, J., To, E., Ashe, K. H. & Matsubara, J. Amyloid-β deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest. Ophthalmol. Vis. Sci. 49, 5136–5143 (2008). Article PubMed Google Scholar Liu, B. et al. Amyloid-peptide vaccinations reduce β-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice. Am. J. Pathol. 175, 2099–2110 (2009). Article CAS PubMed PubMed Central Google Scholar Gasparini, L. et al. Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability. Neurobiol. Aging 32, 419–433 (2011). Article CAS PubMed Google Scholar Koronyo-Hamaoui, M. et al. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage 54 (Suppl. 1), S204–S217 (2011). Article CAS PubMed Google Scholar Buggage, R. R., Chan, C. C. & Nussenblatt, R. B. Ocular manifestations of central nervous system lymphoma. Curr. Opin. Oncol. 13, 137–142 (2001). Article CAS PubMed Google Scholar Buckingham, B. P. et al. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J. Neurosci. 28, 2735–2744 (2008). Article CAS PubMed PubMed Central Google Scholar Calkins, D. J. A neurological perspective on glaucoma. Glaucoma Today [online], (2008). Google Scholar Jakobs, T. C., Libby, R. T., Ben, Y., John, S. W. & Masland, R. H. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J. Cell Biol. 171, 313–325 (2005). Article CAS PubMed PubMed Central Google Scholar Braak, H. & Del Tredici, K. Nervous system pathology in sporadic Parkinson disease. Neurology 70, 1916–1925 (2008). Article PubMed Google Scholar Selkoe, D. J. Alzheimer's disease is a synaptic failure. Science 298, 789–791 (2002). Article CAS PubMed Google Scholar Fischer, L. R. & Glass, J. D. Axonal degeneration in motor neuron disease. Neurodegener. Dis. 4, 431–442 (2007). Article PubMed Google Scholar Gupta, N. & Yucel, Y. H. Glaucoma as a neurodegenerative disease. Curr. Opin. Ophthalmol. 18, 110–114 (2007). Article PubMed Google Scholar Yucel, Y. & Gupta, N. Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration. Prog. Brain Res. 173, 465–478 (2008). Article PubMed Google Scholar Yin, H., Chen, L., Chen, X. & Liu, X. Soluble amyloid β oligomers may contribute to apoptosis of retinal ganglion cells in glaucoma. Med. Hypotheses 71, 77–80 (2008). Article CAS PubMed Google Scholar Janciauskiene, S. & Krakau, T. Alzheimer's peptide: a possible link between glaucoma, exfoliation syndrome and Alzheimer's disease. Acta Ophthalmol. Scand. 79, 328–329 (2001). Article CAS PubMed Google Scholar Yoneda, S. et al. Vitreous fluid levels of β-amyloid(1–42) and tau in patients with retinal diseases. Jpn J. Ophthalmol. 49, 106–108 (2005). Article CAS PubMed Google Scholar Gupta, N., Fong, J., Ang, L. C. & Yucel, Y. H. Retinal tau pathology in human glaucomas. Can. J. Ophthalmol. 43, 53–60 (2008). Article PubMed Google Scholar Goldblum, D., Kipfer-Kauer, A., Sarra, G. M., Wolf, S. & Frueh, B. E. Distribution of amyloid precursor protein and amyloid-β immunoreactivity in DBA/2J glaucomatous mouse retinas. Invest. Ophthalmol. Vis. Sci. 48, 5085–5090 (2007). Article PubMed Google Scholar Guo, L. et al. Targeting amyloid-β in glaucoma treatment. Proc. Natl Acad. Sci. USA 104, 13444–13449 (2007). Article CAS PubMed PubMed Central Google Scholar Johnson, L. V. et al. The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc. Natl Acad. Sci. USA 99, 11830–11835 (2002). Article CAS PubMed PubMed Central Google Scholar Dentchev, T., Milam, A. H., Lee, V. M., Trojanowski, J. Q. & Dunaief, J. L. Amyloid-β is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Mol. Vis. 9, 184–190 (2003). CAS PubMed Google Scholar Yoshida, T. et al. The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. J. Clin. Invest. 115, 2793–2800 (2005). Article CAS PubMed PubMed Central Google Scholar Isas, J. M. et al. Soluble and mature amyloid fibrils in drusen deposits. Invest. Ophthalmol. Vis. Sci. 51, 1304–1310 (2010). Article PubMed PubMed Central Google Scholar Mullins, R. F., Russell, S. R., Anderson, D. H. & Hageman, G. S. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 14, 835–846 (2000). Article CAS PubMed Google Scholar Luibl, V. et al. Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. J. Clin. Invest. 116, 378–385 (2006). Article CAS PubMed PubMed Central Google Scholar Klomp, L. W. & Gitlin, J. D. Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia. Hum. Mol. Genet. 5, 1989–1996 (1996). Article CAS PubMed Google Scholar Ke, Y. & Ming Qian, Z. Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol. 2, 246–253 (2003). Article CAS PubMed Google Scholar Hochstrasser, H. et al. Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology 63, 1912–1917 (2004). Article CAS PubMed Google Scholar Farkas, R. H. et al. Increased expression of iron-regulating genes in monkey and human glaucoma. Invest. Ophthalmol. Vis. Sci. 45, 1410–1417 (2004). Article PubMed Google Scholar Levin, L. A. & Geszvain, K. M. Expression of ceruloplasmin in the retina: induction after optic nerve crush. Invest. Ophthalmol. Vis. Sci. 39, 157–163 (1998). CAS PubMed Google Scholar Ishiura, H. et al. Posterior column ataxia with retinitis pigmentosa in a Japanese family with a novel mutation in FLVCR1. Neurogenetics 12, 117–121 (2011). Article PubMed Google Scholar Rajadhyaksha, A. M. et al. Mutations in FLVCR1 cause posterior column ataxia and retinitis pigmentosa. Am. J. Hum. Genet. 87, 643–654 (2010). Article CAS PubMed PubMed Central Google Scholar London, A. et al. Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages. J. Exp. Med. 208, 23–39 (2011). Article CAS PubMed PubMed Central Google Scholar Shechter, R. et al. Toll-like receptor 4 restricts retinal progenitor cell proliferation. J. Cell Biol. 183, 393–400 (2008). Article CAS PubMed PubMed Central Google Scholar Yoles, E. et al. Protective autoimmunity is a physiological response to CNS trauma. J. Neurosci. 21, 3740–3748 (2001). Article CAS PubMed PubMed Central Google Scholar Anchan, R. M., Reh, T. A., Angello, J., Balliet, A. & Walker, M. EGF and TGF-α stimulate retinal neuroepithelial cell proliferation in vitro. Neuron 6, 923–936 (1991). Article CAS PubMed Google Scholar Yin, Y. et al. Oncomodulin links inflammation to optic nerve regeneration. Proc. Natl Acad. Sci. USA 106, 19587–19592 (2009). Article PubMed PubMed Central Google Scholar Zaverucha-do-Valle, C. et al. Bone marrow mononuclear cells increase retinal ganglion cell survival and axon regeneration in the adult rat. Cell Transplant. 20, 391–406 (2011). Article PubMed Google Scholar Wong, T. Y. Is retinal photography useful in the measurement of stroke risk? Lancet Neurol. 3, 179–183 (2004). Article PubMed Google Scholar De Silva, D. A. et al. Retinal microvascular changes and subsequent vascular events after ischemic stroke. Neurology 77, 896–903 (2011). Article CAS PubMed Google Scholar Frohman, E. M., Balcer, L. J. & Calabresi, P. A. Multiple sclerosis: can retinal imaging accurately detect optic neuritis? Nat. Rev. Neurol. 6, 125–126 (2010). Article PubMed Google Scholar Naismith, R. T. et al. Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis. Neurology 73, 46–52 (2009). Article CAS PubMed PubMed Central Google Scholar Petzold, A. et al. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol. 9, 921–932 (2010). Article PubMed Google Scholar Henderson, A. P. et al. An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain 131, 277–287 (2008). PubMed Google Scholar Gordon-Lipkin, E. et al. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 69, 1603–1609 (2007). Article CAS PubMed Google Scholar Grazioli, E. et al. Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis. J. Neurol. Sci. 268, 12–17 (2008). Article PubMed Google Scholar Lennon, V. A. et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364, 2106–2112 (2004). Article CAS PubMed Google Scholar Ratchford, J. N. et al. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 73, 302–308 (2009). Article CAS PubMed PubMed Central Google Scholar Nakamura, M. et al. Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica. Graefes Arch. Clin. Exp. Ophthalmol. 248, 1777–1785 (2010). Article CAS PubMed Google Scholar Naismith, R. T. et al. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 72, 1077–1082 (2009). Article CAS PubMed PubMed Central Google Scholar Kesler, A., Vakhapova, V., Korczyn, A. D., Naftaliev, E. & Neudorfer, M. Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin. Neurol. Neurosurg. 113, 523–526 (2011). Article PubMed Google Scholar Paquet, C. et al. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci. Lett. 420, 97–99 (2007). Article CAS PubMed Google Scholar Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353–356 (2002). Article CAS PubMed Google Scholar Melnikova, I. Therapies for Alzheimer's disease. Nat. Rev. Drug Discov. 6, 341–342 (2007). Article CAS PubMed Google Scholar Schenk, D. et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173–177 (1999). Article CAS PubMed Google Scholar Ding, J. D. et al. Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proc. Natl Acad. Sci. USA 108, E279–E287 (2011). Article PubMed PubMed Central Google Scholar Ding, J. D. et al. Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies: anti-amyloid-β antibody attenuates pathologies in an age-related macular degeneration mouse model. Vision Res. 48, 339–345 (2008). Article CAS PubMed Google Scholar Niikura, T., Hashimoto, Y., Tajima, H. & Nishimoto, I. Death and survival of neuronal cells exposed to Alzheimer's insults. J. Neurosci. Res. 70, 380–391 (2002). Article CAS PubMed Google Scholar Men, J., Zhang, X., Yang, Y. & Gao, D. An AD-related neuroprotector rescues transformed rat retinal ganglion cells from CoCl2-induced apoptosis. J. Mol. Neurosci. 47, 144–149 (2012). Article CAS PubMed Google Scholar Frenkel, D., Maron, R., Burt, D. S. & Weiner, H. L. Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears β-amyloid in a mouse model of Alzheimer disease. J. Clin. Invest. 115, 2423–2433 (2005). Article CAS PubMed PubMed Central Google Scholar Frenkel, D. et al. Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells. J. Immunol. 171, 6549–6555 (2003). Article CAS PubMed Google Scholar Ben Simon, G. J., Bakalash, S., Aloni, E. & Rosner, M. A rat model for acute rise in intraocular pressure: immune modulation as a therapeutic strategy. Am. J. Ophthalmol. 141, 1105–1111 (2006). Article PubMed Google Scholar Schori, H. et al. Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc. Natl Acad. Sci. USA 98, 3398–3403 (2001). Article CAS PubMed PubMed Central Google Scholar Mitne, S. et al. The potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation. Clin. Ophthalmol. 5, 991–997 (2011). Article PubMed PubMed Central Google Scholar US National Library of Medicine. A randomized, double-blind, placebo-controlled, multicenter study of the effects of glatiramer acetate (GA) on the retinal nerve fiber layer (RNFL) and visual function in patients with a first episode of acute optic neuritis (AON). US National Library of Medicine. ClinicalTrials.gov[online], (2011). US National Library of Medicine. Copaxone in age related macular degeneration. ClinicalTrials.gov[online], (2007). US National Library of Medicine. Weekly vaccination with copaxone as a potential therapy for dry age-related macular degeneration. ClinicalTrials.gov [online], (2008). Yucel, Y. H. et al. Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma. Arch. Ophthalmol. 124, 217–225 (2006). Article CAS PubMed Google Scholar [No authors listed] Allergan reports fourth quarter operating results and announces restructuring. Allergan.com [online], (2008). Samples, J. R. in Ophthalmology Management (Wolters Kluwer Pharma Solutions Inc., Ambler, PA, 2011). Google Scholar Wostyn, P., Audenaert, K. & De Deyn, P. P. Alzheimer's disease: cerebral glaucoma? Med. Hypotheses 74, 973–977 (2010). Article CAS PubMed Google Scholar |